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Abstract 
Background: It has been hypothesized that the body's response to anesthesia techniques can increase risk of 
cancer recurrence and metastatic disease after surgery and also can modulate immune responses. Some acute 
inflammatory markers have been measured to survey the immunomodulatory effect of anesthesia, but in this 
research, we studied the plasma level of CD30 and YKL-40 gene expression which can present major changes 
of the immune system. 
Materials and Methods: Our study was a controlled before and after study. 34 women with biopsy-
proven breast cancer were randomized to receive either propofol general anesthesia (n=17) or standard 
isoflurane general anesthesia (n=17). There were no significant differences between the two patient groups in 
age, body weight, and height, length of general anesthesia, operative time and group of surgery. The blood 
samples were collected in two different sets, before anesthesia and 72-h postoperatively. Soluble CD30 
(sCD30) plasma level was measured by ELISA and YKL-40/CHI3L1 gene expression was evaluated by real-
time-PCR. 
Results: The results showed that the anesthetics, propofol and isoflurane, have no effect on the expression of 
YKL-40. Despite increased in the expression of YKL-40 that was observed in patients receiving isoflurane, 
this increase was not statistically significant. There was no significant increase or decrease in plasma 
concentrations of sCD30. 
Conclusion: YKL-40 and sCD30 are not affected by isoflurane or propofol.  So, in immunological perspective, 
there is no preference in use of isoflurane or propofol in breast cancer patients. 
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Breast cancer is one of the main causes of cancer-
related death in women and associated morbidity and 
mortality relates mainly to metastatic disease and not 
the primary tumor
1
. A number of preoperative factors 
Lak et al.                                                          YKL-40 Gene Expression and Plasma Levels of CD30 are not Affected… 
NBM                                                                            160                                   Novelty in Biomedicine 2016, 4, 159-65 
during primary breast cancer surgery, including 
anesthetic technique, might influence whether 
minimal residual micro-metastases elimination or 
full-blown metastatic disease. Major surgery is 
associated with immunosuppression, which can 
facilitate angiogenesis, tumor metastasis, and tumor 
invasion
1-3
. There is increasing evidence from 
experimental studies and a limited number of clinical 
studies that some anesthetic drugs may be 




YKL-40 is a glycoprotein involved in cellular 
growth, migration, and the inflammatory process. 
Overexpression of YKL-40 has been associated with 
worse prognosis in various localized and metastatic 
malignancies, including breast cancer
11,12
. CD30 and 
CD30L are members of the tumor necrosis factor 
receptor and TNF super family. It is an important 
costimulatory molecule and a marker for the 
physiological balance between TH1/TH2/TH17/Treg 
immune responses
13
. Ligation of CD30 on normal 
effector T cells induces interleukin 13 (IL13) 
productions. IL-13 can promote cancer progression. 
YKL-40 is a ligand for the IL13 receptor which acts 
as a decoy receptor
14,15
. 
We sought to determine the postoperatively 
immunomodulatory effects of propofol general 
anesthesia in comparison with standard isoflurane 
general anesthesia among breast cancer patients. In 
this research, we studied the impact of anesthetic 
regimes by assessment of two biomarkers (YKL-40 
and CD30) which regulate and modify immune 
responses to tumor. 
Methods 
Study subjects: This study was conducted after 
approval by the local ethics committee. Thirty-four 
women undergoing surgery for biopsy-proven 
primary breast cancer were randomized to receive 
either propofol general anesthesia or standard 
isoflurane general anesthesia. Patients had been 
randomly assigned for the study by using prepared 
opaque envelopes. Patients with a history of 
smoking, anemia, endocrine disorders, immune 
system disorders, malignant disease, chronic 
inflammatory disease, marked obesity, kidney or 
liver disorders, or steroid therapy were not studied. 
The inclusion criteria were women aged 18–60 years, 
undergoing mastectomy or wide local tumor excision 
with or without axillary node sampling or excision. 
There were no significant differences between the two 
patient groups in age, body weight, and height (Table 
1), and also operative time and group of surgery. 
Patients were consented to contribute a sample of 
venous blood before operation and 3 days after 
operation. Based on previous studies
16
 a peak in 
immunosuppression is said to occur at day three. 
Hence, it can be suggested that the early postoperative 
period represents an immunological window of 
opportunity during which the extracellular milieu may 
be increasingly permissive to minimal residual disease 
growth and spread.  Blood samples (10 ml each) were 
drawn immediately before induction of anesthesia and 
72h postoperatively. Separated plasma samples and 
buffy coat were stored at -80°C until assayed.  
Anesthesia: All patients were premeditated with 
diazepam 5 mg orally 2 h pre-operatively. The patients 
were randomly allocated to receive either propofol 
(n=17) or isoflurane (n=17). For the propofol group, 
anesthesia was induced with 1–2 mg.kg
-1
 propofol and 
0.5-l g.kg
-1



















thereafter. For the isoflurane group, anesthesia was 
induced with 3–4 mg.kg
-1
 thiopental and 0.5 mg.kg
-1
 
atracurium. Anesthesia was maintained with isoflurane 
0.5–1%. In both groups fentanyl was given at 2-4 
mg.kg
-1
, neuromuscular blockade was maintained with 
intermittent doses of atracurium and ventilation was 
controlled to obtain an end-tidal carbon dioxide 
tension of 30-35 mmHg. Nitrous oxide was not used in 
either group. Anesthetists unaware of the purpose of 
the study performed all the anesthetic procedures 
described above. 
CD30 Plasma Levels: To measure the plasma levels 
of soluble CD30 (sCD30), a sandwich enzyme-linked 
immunosorbent assay was used (human sCD30, 
Invitrogen, USA). Briefly, subjects’ plasma was added 
to peroxidase-conjugated mouse anti-CD30 
monoclonal antibodies. After 3 h incubation and 
washing, to remove unbound materials, a chromogenic 
substrate was added to the wells; then, the enzyme 
reaction was stopped and the absorbance on a spectro-
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photometer using 450nm. 
YKL-40 Gene Expression: Blood cells were used 
for real time PCR analysis. RNA was purified from 
cell with RNX-Plus kit (SinaClon, IRAN) following 
the manufacturer’s instructions. One µg of total RNA 
was used for synthesizing cDNA by using a 
commercial kit (Intron, Korea). cDNA was used for 
the real time PCR reaction in the mixture of primers 
and the 2X Maxima SYBR Green q-PCR Master Mix 
(Thermo Fisher Scientific, Waltham, U.S.). 
The specific primers were designed to amplify a 
141bp fragment of the human CHI3L1 (GenBankTM 
code NM_001276) gene, using Beacon Designer 
software. To normalize differences in efficacy of 
sample extraction, we used beta-actin as a 
housekeeping gene. The sequences of primers 
represented in (Table 2). A non-template control 
(NTC) consisting of water in place of template DNA 
was used in each run.  The analysis of melting curve 
was performed in the temperature range of 65 to 
95C at the end of each run and specificity of all 
individual amplification reactions was confirmed by 
melting curve analysis and also gel electrophoresis 
(Fig 1). 
Statistical Analysis: Statistical analyses were 
performed using the SPSS program (v.17; SPSS, 
Chicago, IL). The student's t-test was performed to 
compare the groups with normal distribution. The 
Mann–Whitney U test was used in the case of non-
normal distribution. P=0.05 was considered as 
statistically significant. The relative levels of mRNA 
were analyzed by the REST 2009 Software 
(QIAGEN). 
Results 
Soluble CD30 (sCD30): Pre-incisional values of 
sCD30 did not differ significantly between the two 
groups (p=0.77). Before surgery, all patients, had 
sCD30 levels more than 17.5 pg/ml (17.5-86.5 
pg/ml). The plasma concentration sCD30 among 
patients after surgery ranged from 13-70 pg/ml (Fig. 
2). 
In group of isofluran, the sCD30 levels   did not 
show any significant change (P=0.84) in their 
concentration throughout the study period. In this 
group, pre-incisional value of sCD30 ranged from 
18-64.6 pg/ml and postoperative value of sCD30 
ranged from 13-70 pg/ml (Fig. 2). In group of 
propofol, the sCD30 levels did not show any 
significant change in their concentration throughout 
the study period (P=0.83), pre-incisional value of 
sCD30 ranged from 17.5-86.5 pg/ml and postoperative 
value of sCD30 ranged from 19-61.5 pg/ml in this 
group (Fig. 2). Postoperative sCD30 plasma levels of 
isofluran group in relation to the preoperative period 
revealed a wide rang. Suggesting the changes is more 
pronounced during isofluran than propofol anesthesia. 
However; mean comparison of sCD30 levels between 
groups did not show a statistically significant 
difference after surgery (P=0.81).  
There was not any significant correlation between 
plasma levels of sCD30 and absolute WBC counts and 
age among our study subject (data not shown).  
YKL-40 gene expression rate in blood cells: At 
baseline (before surgery), the YKL-40 gene expression 
rate did not show a significant difference (P=0.065) 
between groups (Table 3). Postoperatively YKL-40 
gene expression rate did not show a significant 
difference (P=0.068), as well. Therefore the YKL-40 
gene expression is not affected by anesthetic drugs. 
Despite of propofol group that postoperative 
expression in relation preoperative expression was 
1.092 fold change (P=0.65), the YKL-40 gene 
expression rate showed slightly increased after surgery 
among isoflurane group. Pre-incisional value of YKL-
40 fold change was 0.88 less than postoperative but 
this difference did not show statistically significant 
(P=0.86). Overlay our data according to the YKL-40 
gene expression, suggesting that propofol may not be 
preferred over isofluran. 
Discussion 
In tumor patients postoperative immunosuppression 
could cause spreading minimal residual diseases, so 
surgery is a double-edged sword which in one hand is 
a tumor treatment and on the other hand may be 
ending with metastatic disease. Preoperative factors 
influencing immune components and might be 
increased the risk of recurrence or metastasis. There is 
a question:  can anesthetic technique for surgery affect 
immune responses? To answer this question we 
compered the effects of isofluran and propofol 
anesthesia on sCD30 plasma level and YKL-40 gene 
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expression rate in blood cell during mastectomy 
operation. The results showed that the anesthetics, 
propofol and isoflurane, have no effect on the gene 
expression of YKL-40 in blood cells and also plasma 
Table 1: Demographic data in both groups. Values are Mean (SD) or number (Proportion). 
 Isoflurane (n=17) Propofol (n=17)  
Demographic Detail          P-value 
- Female Female Gender 
0.772 44.64±2.3 44.94±2.1 Age Average(year)  
 
0.179 70.11±2.3 70.29±1.8 Weight Average(Kg) 
 
0.357 160.76±1.1 160.70±1.6 Height Average(Cm) 
 
0.624 28.7±1.2 29.1±1.6 (Kg/m2)BMI 
 
- 120 120 Operation Length (min) 
Clinical History 
 - - Asthma 
 - - Inflammation 
 - - Operation 
 - - Blood transfer 
 - - Smoking 
 - - Hormone Therapy 
First Blood Sample (Before) 
0.660 6.74±0.33 7.30±0.29 W.B.C (3^/mm) 
 
0.721 4.87±0.17 4.36±0.12 R.B.C (6^/mm) 
 
0.582 224±3.1 245±2.5 PLT (g/dl) 
 
0.300 66.12±2.5 75±2.8 Neut  )%(  
 
0.608 32.35±1.9 31.29±1.3 Lymph  )%(  
 
0.074 12.02±0.42 12.96±0.16 HGB (g/dl) 
 
Second Blood Sample (After) 
0.398 7.76±0.40 7.28±0.32 W.B.C (3^/mm) 
 
0.754 4.92±0.51 4.64±0.29 R.B.C (6^/mm) 
 
0.234 258 250 PLT (g/dl) 
 
0.164 73.05±3.6 75.11±2.2 Neut  )%(  
 
0. 342 27.64±2.7  26.70±1.60 Lymph  )%(  
 




Table 2: The primers sequences of genes of interest and housekeeping genes. 
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concentrations of sCD30. 
Recently, Baki et al. assess the effect of propofol 
versus desflurane anesthesia on systemic immune 
modulation and central nervous system on patients 
undergoing coronary artery bypass grafting and 
found that in terms of S100β plasma levels propofol 
is more preferable for anesthetic management
17
. 
However, this study were assessed, the effects of 
isoflurane anesthesia based on the acute 
inflammatory markers. A comparable study in 
Finland supports this idea that there isn’t notably 
adverse immune response after surgery and 
anaesthesia
18
, researchers compared the effects of 
propofol-based (n=15) and isoflurane-based 
anaesthesia (n=15) on mucous host defenses by 
measuring the salivary flow and the 
concentrations/activities of salivary total protein and 
amylase, and of salivary immunological (IgA, IgG 
and IgM) and non-immunoglobulin defense factors 
(lysozyme, myeloperoxidase, total salivary 
peroxidase and thiocyanate) in patients undergoing 
elective abdominal hysterectomy. The changes were 
similar in both groups. In contrast to our findings, 
Inada et al.
19
 found that “The Th1⁄Th2 ratio 
decreased significantly after isoflurane anaesthesia, 
while it did not change after propofol anaesthesia. 
They concluded that propofol anaesthesia attenuated 
the surgical stress-induced adverse immune 
response.However; an obvious limitation of this 
study was the size of the population. A small sample 
size (n=9 in each group) greatly underpowered any 
potential associations. In another study, researcher 
considered 15 patients in two groups of propofol and 
isofluran and evaluate whether propofol stimulates 
the activation and differentiation of T helper cells in 
patients undergoing pulmonary lobectomy. They 
found that interferon-γ: interleukin-4 plasma levels 
increased with propofol but showed no change with 
isoflurane. However, they considered brief periods 




Our study suggests that isofluran and propofol could 
not lead to a major change in immune system 
homeostasis. However; our study could not reject 
different biological impact of these drugs. Recently, 
there is a theory that using isoflurane could increase 
alzheimer risk and cause hippocampi cells apoptosis
21
. 
So immunological approach is not enough to choose 
one of them and all the other aspects should be 
surveyed too. 
Conclusion 
Based on our data there is no advantage in using 
Table 3: YKL-40 mRNA expression among isoflurane group in relation to propofol group before surgery (A) and after 
surgery (B). 
Gene Type Reaction Efficiency Expression Std. Error 95% C.I. P(H1) Result 
A 
B-Actin REF 0.8038 1.000     
YKL-40 TRG 0.8482 1.401 0.055 - 35.562 0.010 - 377.068 0.652  
B 
B-Actin REF 0.8140 1.000     





Figure 1. The specificity of PCR products.  
To verify the specificity, the dissociation curves of PCR products 
were generated. The y-axis was expressed as first derivative of 
the fluorescence as a function of temperature. The PCR products 
were analyzed agarose gel electrophoresis, followed by ethidium 
bromide staining. 
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isoflurane or propofol in mastectomy. YKL-40 and 
sCD30 are not affected by isoflurane or propofol.  So 
that, from an immunological perspective, there is no 
preference in use of isoflurane or propofol in breast 
cancer patients. Actually, based on the patient’s 
condition, diagnose of anesthesiologists, and other 
factors such as the price and the availability of drugs 
either propofol or isoflurane could be used in 
mastectomy candidate patients. 
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